Structural characterization of protective non-neutralizing antibodies targeting Crimean-Congo hemorrhagic fever virus
There are currently no approved treatments for Crimean-Congo Hemorrhagic Fever Virus (CCHFV) infection. In this study, the authors structurally characterize the epitope targeted by protective non-neutralizing mouse and human antibodies and provide insights into their broad range potential against va...
Main Authors: | Ian A. Durie, Zahra R. Tehrani, Elif Karaaslan, Teresa E. Sorvillo, Jack McGuire, Joseph W. Golden, Stephen R. Welch, Markus H. Kainulainen, Jessica R. Harmon, Jarrod J. Mousa, David Gonzalez, Suzanne Enos, Iftihar Koksal, Gurdal Yilmaz, Hanife Nur Karakoc, Sanaz Hamidi, Cansu Albay, Jessica R. Spengler, Christina F. Spiropoulou, Aura R. Garrison, Mohammad M. Sajadi, Éric Bergeron, Scott D. Pegan |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-11-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-022-34923-0 |
Similar Items
-
Single-dose replicon particle vaccine provides complete protection against Crimean-Congo hemorrhagic fever virus in mice
by: Florine E. M. Scholte, et al.
Published: (2019-01-01) -
Vaccination with the Crimean-Congo hemorrhagic fever virus viral replicon vaccine induces NP-based T-cell activation and antibodies possessing Fc-mediated effector functions
by: F. E. M. Scholte, et al.
Published: (2023-08-01) -
Molecular Insights into Crimean-Congo Hemorrhagic Fever Virus
by: Marko Zivcec, et al.
Published: (2016-04-01) -
The Crimean-Congo Hemorrhagic Fever Virus NSm Protein Is Dispensable for Growth In Vitro and Disease in Ifnar<sup>-/-</sup> Mice
by: Stephen R. Welch, et al.
Published: (2020-05-01) -
Tularemia Associated with Natural Water Sources: Two Case Reports and Review of the Literature
by: Hanife Nur KARAKOÇ, et al.
Published: (2017-12-01)